Market Overview:
MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Metagenomics Market, The Global Metagenomics Market was valued at around USD 2.52 billion in 2024 and is projected to reach USD 5.82 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18.1% during the forecast period, i.e., 2025-30. The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Metagenomics Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.
Industry Outlook & Forecasts:
- Forecast Period: 2025-2030
- Market Size in 2024: USD 2.52 billion
- CAGR (2025-2030): 18.1%
Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/metagenomics-market.html
Global Metagenomics Market Segmentation Breakdown:
- By Product Type
- Software and Tools – Market Size & Forecast 2020-2030F, USD Million
- Data Analysis Software- Market Size & Forecast 2020-2030F, USD Million
- Bioinformatics Solutions- Market Size & Forecast 2020-2030F, USD Million
- Sequencing Platforms – Market Size & Forecast 2020-2030F, USD Million
- Kits and Reagents – Market Size & Forecast 2020-2030F, USD Million
- Library Preparation Kits – Market Size & Forecast 2020-2030F, USD Million
- Sample Extraction Kits – Market Size & Forecast 2020-2030F, USD Million
- Software and Tools – Market Size & Forecast 2020-2030F, USD Million
Kits and Reagents is the leading segment with approximately 50% share of the Global Metagenomics Market. The segment is dominating due to its essential role in many biological and genomic processes.
- By Technology
- Shotgun Sequencing – Market Size & Forecast 2020-2030F, USD Million
- 16S Sequencing – Market Size & Forecast 2020-2030F, USD Million
- Whole Genome Sequencing – Market Size & Forecast 2020-2030F, USD Million
- Others – Market Size & Forecast 2020-2030F, USD Million
- By Application
- Environmental – Market Size & Forecast 2020-2030F, USD Million
- Clinical Metagenomics – Market Size & Forecast 2020-2030F, USD Million
- Drugs Discovery – Market Size & Forecast 2020-2030F, USD Million
- Biotechnology – Market Size & Forecast 2020-2030F, USD Million
- Food & Nutrition – Market Size & Forecast 2020-2030F, USD Million
- Others – Market Size & Forecast 2020-2030F, USD Million
Clinical Metagenomics holds the largest market share, capturing around 35% share because of its crucial impact on the healthcare sector for treatment and diagnostics.
Geographical Growth Insights:
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
North America holds a dominant 40% market share in metagenomics worldwide, owing to its strong research environment and technological developments. Significant investment in the field is driven by the region’s many internationally recognized universities, research centers, and biotechnology companies.
MarkNtel Advisors Highlights Key Market Drivers for Metagenomics Market:
Rising Frequency of Infectious Disease – The Global Metagenomics Market is driven by the growing cases of infectious diseases. In 2023, more than 52 million, around 33% of the global annual deaths occurred due to infectious diseases which is the leading cause of morbidity and mortality and nearly half of the population is at risk of new emerging diseases. To understand the reason behind the spread of the existing diseases and their patterns, the reason for the emergence of new infectious diseases, and to combat the pathogens, advanced tools are needed. Metagenomics facilitates the rapid identification of pathogenic bacteria and viruses by the direct analysis of the genetic material of entire microbial communities from patient samples.
Moreover, the study is more valuable in clinics as timely diagnosis is important for better treatment. Scientists can identify pathogens by analyzing the genetic sequences from a sample, which enables quicker and more precise diagnosis. Metagenomics also aids in the study of the interaction of these pathogens with their hosts and surroundings, offering insights into their resistance mechanisms and behavior. In addition to innovation in metagenomics technologies, the growing demand also facilitates research and development which propels market expansion. For instance,
- In March 2024, The discovery of 393 viral species including arboviruses associated with mosquitos in a study conducted on 2438 mosquitoes throughout China which revealed geographic hotspots of viral diversity and a close connection between individual mosquito viromes with host phylogeny.
A Comprehensive Analysis of Leading Companies in Global Metagenomics Market
Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Illumina Inc., Perkin Elmer Inc., Symbio Scientific Pvt. ltd., Merck KgaA, Eurofins Scientific, Macrogen Inc., Oxford Nanopore Technology, QIAGEN, Promega Corporation, Infobio, and Others
Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/metagenomics-market.html
Global Metagenomics Industry Recent Development:
- June 2024: Thermo Fisher Scientific Inc. unveiled the Thermo Scientific Stellar mass spectrometer, a novel method that enables researchers to progress their translational omics research and produce groundbreaking discoveries.
- January 2023: QIAGEN announced that it had closed the acquisition of Verogen and was utilizing GS technology to improve the future of human identification (HID) and forensics.
What are the growth Opportunity driving the Global Metagenomics Market?
Emerging Opportunities in Biotechnology Innovation – Biotechnology innovations are presenting a significant growth opportunity for the Global Metagenomics Market. The new technology is enhancing the ability to analyze complex microbial communities in extraordinary ways. To extract genetic information from a variety of samples, advanced sequencing methods are becoming more efficient and economical. Researchers can investigate novel metagenomics applications in domains like environmental science, agriculture, and medicine with these advancements. Moreover, the development of bioinformatics solutions for data analysis through biotechnological advancements provides a better understanding of the interactions and functions of microbes. The demand for metagenomics applications will further create ample opportunity as the sector is emphasizing the study of microbial diversity and its effects on ecosystems and human health. Companies can take benefit of this dynamic market by innovating and expanding their offerings. For instances,
- In January 2024, Eurofins Genomics partnered with 30 labs in Seattle to open a certified sequencing lab in Bothell Washington using the Oxford Nanopore platform for quick 12-hour results.
“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”
Key Advantages of the Report by MarkNtel Advisors:
Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key subsegments, benefiting both market leaders and new entrants.
Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.
Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.
Note: If you need additional information not included in the report, we can customize it to suit your requirements.
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/metagenomics-market.html
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
More Research Studies:
Global Metagenomics Market – The Global Metagenomics Market size was valued at around USD 0.98 billion in 2024 and is projected to reach USD 5.82 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18.1% during the forecast period, i.e., 2025-30.
Global Metagenomics Market – The Global Metagenomics Market was valued at around USD 2.52 billion in 2024 and is projected to reach USD 5.82 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18.1% during the forecast period, i.e., 2025-30.
Global Metagenomics Market – The Global Metagenomics Market was valued at around USD 55 billion in 2024 and is projected to reach USD 5.82 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18.1% during the forecast period, i.e., 2025-30.
Media Contact:
Company Name: MarkNtel Advisors
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Email: sales@marknteladvisors.com
Phone: +1 628 895 8081, +91 120 4278433
Website: www.marknteladvisors.com/
More Stories
Maximize Your Medical Practice’s Growth with Social Media in 2025
Stussy Hoodie A Streetwear Icon That Defines Style and Comfort
Hero Homes The Palatial: A Luxurious Address in Gurgaon